Stocks

The table gives an overview of all stocks, alphabetically sorted.
 Nanexa NANEXA Mar 3, 2021 10.20 -2.39   
 Nanoform Finland NANOFS Mar 3, 2021 85.00 -0.58   
 Nanologica NICA Mar 3, 2021 17.90 -2.45   
 Napatech NAPAO Mar 3, 2021 12.56 0.00   
 NASDAQ OMX Small Cap Sweden GI NOMXSCSEGI Mar 3, 2021 3 861.23 +0.26   
 NASDAQ OMX Small Cap Sweden PI NOMXSCSE Mar 3, 2021 2 580.62 +0.26   
 NattoPharma NATTOO Mar 3, 2021 35.00 -3.85   
 Navamedic NAVAO Mar 3, 2021 18.50 0.00   
 NAXS NAXS Mar 3, 2021 53.80 -1.10   
 NCAB Group NCAB Mar 3, 2021 341.00 -2.01   
 NCC A NCCA Mar 3, 2021 146.00 +1.39   
 NCC B NCCB Mar 3, 2021 144.80 +1.97   
 Nederman Holding NMAN Mar 3, 2021 141.00 -1.05   
 Nekkar NKRO Mar 3, 2021 8.70 0.00   
 NEL NELO Mar 3, 2021 24.30 -8.95   
 Nelly Group NELLY Mar 3, 2021 34.35 +0.15   
 NENT Group A NENTA Mar 3, 2021 397.00 -0.75   
 NENT Group B NENTB Mar 3, 2021 392.20 +0.51   
 NeoDynamics NEOD Mar 3, 2021 2.96 -1.33   
 Nepa NEPA Mar 3, 2021 36.50 +2.24   
 Net Insight B NETIB Mar 3, 2021 1.98 -3.41   
 Net Trading Group NTGR Mar 3, 2021 0.54 +1.89   
 NetJobs Group NJOB Mar 3, 2021 0.86 +22.86   
 Netmore Group B NETMB Mar 3, 2021 1.18 -1.67   
 New Equity Venture International B NEVIB Mar 3, 2021 24.40 +7.02   
 New Nordic Healthbrands NNH Mar 3, 2021 56.40 0.00   
 New Wave B NEWAB Mar 3, 2021 72.70 +0.97   
 News55 N55 Mar 3, 2021 1.80 -1.64   
 Newton Nordic NEWTON Mar 3, 2021 0.77 0.00   
 Nexam Chemical Holding NEXAM Mar 3, 2021 14.40 +2.13   
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK